Oramed Pharmaceuticals (ORMP): Shareholder Letter Spurs Bullish Trend

After releasing a letter to shareholders, Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) shares has seen a significant increase on the US stock charts. As of the latest current-market check, ORMP stock price increased 18.82% to $2.66. Program For Stock Repurchases And Strategic Update Nadav Kidron, the CEO of Oramed Pharmaceuticals (ORMP), sent a detailed letter to ...

Stocks TelegraphJun 26 13:16 ET

Express News | Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a $20 Million Buyback Program and Finalized Its Joint Venture With Hefei Tianhui Biotech

BenzingaJun 26 11:41 ET

Express News | Oramed Pharmaceuticals And Hefei Tianhui Biotech Finalize Joint Venture; JV To Receive Capital Infusion With HTIT Committing $70M In Cash And Oramed Investing $25M In Cash and Stock

BenzingaJun 26 09:15 ET

Express News | Oramed Pharmaceuticals: Htit Committing $70 Mln in Cash, Co Investing $25 Mln in Cash & Stock in Jv

ReutersJun 26 09:12 ET

Express News | Oramed Pharmaceuticals Inc: Jv With Chinese Partner, Htit

ReutersJun 26 09:12 ET

Express News | Oramed Pharmaceuticals Authorizes $20M Buyback

BenzingaJun 26 09:09 ET